These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 6177157

  • 1. Autoradiographic localization of 8-methoxypsoralen in psoriasis skin in vitro.
    Bertaux B, Dubertret L, Moreno G.
    Acta Derm Venereol; 1981; 61(6):481-5. PubMed ID: 6177157
    [Abstract] [Full Text] [Related]

  • 2. The binding of 8-methoxypsoralen to nuclear DNA of UVA irradiated human fibroblasts in vitro.
    Bredberg A, Lambert B, Swanbeck G, Thyresson-Hök M.
    Acta Derm Venereol; 1977; 57(5):389-91. PubMed ID: 73303
    [Abstract] [Full Text] [Related]

  • 3. DNA in psoriatic epidermis.
    Sondergaard J, Lerche A, Bohr V, Leik V, Wadskov S.
    Acta Derm Venereol Suppl (Stockh); 1979; 87():59-63. PubMed ID: 294785
    [Abstract] [Full Text] [Related]

  • 4. Bioavailability study of two different 8-methoxypsoralen (8-MOP) preparations in patients receiving PUVA therapy.
    Nørgaard M, Hueg B, Staberg B.
    Photodermatol; 1985 Aug; 2(4):252-6. PubMed ID: 3903679
    [Abstract] [Full Text] [Related]

  • 5. Detection and quantification of 8-methoxypsoralen-DNA adducts.
    Santella RM, Yang XY, DeLeo VA, Gasparro FP.
    IARC Sci Publ; 1988 Aug; (89):333-40. PubMed ID: 3058601
    [Abstract] [Full Text] [Related]

  • 6. 8-Methoxypsoralen-DNA adducts in patients treated with 8-methoxypsoralen and ultraviolet A light.
    Yang XY, Gasparro FP, DeLeo VA, Santella RM.
    J Invest Dermatol; 1989 Jan; 92(1):59-63. PubMed ID: 2642513
    [Abstract] [Full Text] [Related]

  • 7. Absorption, distribution, and excretion of 8-methoxypsoralen in HRA/Skh mice.
    Muni IA, Schneider FH, Olsson TA, King M.
    Natl Cancer Inst Monogr; 1984 Dec; 66():85-90. PubMed ID: 6531044
    [Abstract] [Full Text] [Related]

  • 8. Validation of a microdialysis-gas chromatographic-mass spectrometric method to assess 8-methoxypsoralen in psoriatic patient dermis.
    Leveque N, Muret P, Mary S, Bérard M, Makki S, Pierre Kantelip J, Humbert P.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov 15; 780(1):119-27. PubMed ID: 12383487
    [Abstract] [Full Text] [Related]

  • 9. Photobinding of 8-methoxypsoralen at psoriasis skin.
    Meffert H, Sönnichsen N.
    Acta Derm Venereol; 1982 Nov 15; 62(5):461-2. PubMed ID: 6183911
    [No Abstract] [Full Text] [Related]

  • 10. [PUVA therapy: decrease of the 8-methoxypsoralen level following local administration].
    Meffert H, Metz D.
    Dermatol Monatsschr; 1980 Aug 15; 166(8):566-7. PubMed ID: 7461250
    [No Abstract] [Full Text] [Related]

  • 11. Penetration kinetics of 8-methoxypsoralen after 8-methoxypsoralen bath procedure with and without UVA irradiation.
    Neumann NJ, Grosse OJ, Ruzicka T, Lehmann P.
    Skin Pharmacol Appl Skin Physiol; 2001 Aug 15; 14(4):210-6. PubMed ID: 11464103
    [Abstract] [Full Text] [Related]

  • 12. Photochemotherapy and the eye: photoprotective factors.
    Glew WB, McKeever G, Roberts WP, Malinin G, Nigra TP.
    Trans Am Ophthalmol Soc; 1980 Aug 15; 78():243-54. PubMed ID: 7257058
    [Abstract] [Full Text] [Related]

  • 13. Influenced of food on the kinetics of 8-methoxypsoralen in serum and suction blister fluid in psoriatic patients.
    Herfst MJ, De Wolff FA.
    Eur J Clin Pharmacol; 1982 Aug 15; 23(1):75-80. PubMed ID: 7128674
    [Abstract] [Full Text] [Related]

  • 14. Determination of 8-methoxypsoralen kinetics: a relevant factor in the treatment of psoriasis by psoralen plus ultraviolet A therapy.
    Bonnot D, Béani JC, Boitard M, Reymond JL, Bériel H, Amblard P.
    Photodermatol Photoimmunol Photomed; 1994 Feb 15; 10(1):33-7. PubMed ID: 8180098
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of treatment with UV-light (365 nm) and 8-methoxypsoralen on chromosomes of healthy persons and psoriatic patients.
    Löber G, Kittler L, Beensen V, Schaarschmidt H, Knopf B.
    Biomed Biochim Acta; 1986 Feb 15; 45(3):343-51. PubMed ID: 3707553
    [Abstract] [Full Text] [Related]

  • 16. Autoradiographic study of the effects of psoralen and ultraviolet light on DNA, RNA and protein synthesis in cultured keratinocytes and psoriatic skin.
    Bertaux B, Moreno G, Vinzens F, Dubertret L.
    Skin Pharmacol; 1988 Feb 15; 1(4):250-8. PubMed ID: 2483114
    [Abstract] [Full Text] [Related]

  • 17. [Photochemotherapy with 8-methoxypsoralen and UVA. III. Fluorescent microscopy studies of binding and transport of 8-MOP in the human skin].
    Meffert H, Varthelmes H, Metz D, Sönnichsen N.
    Dermatol Monatsschr; 1977 Aug 15; 163(8):619-27. PubMed ID: 913739
    [No Abstract] [Full Text] [Related]

  • 18. 3H-thymidine labelling of epidermis and dermal infiltrate in psoriatic erythroderma.
    de la Brassinne M, Lachapelle JM.
    Acta Derm Venereol; 1975 Aug 15; 55(3):171-4. PubMed ID: 50686
    [Abstract] [Full Text] [Related]

  • 19. Effect of alpha-tocopherol and di-butyl-hydroxytoluene (BHT) on UV-A-induced photobinding of 8-methoxypsoralen to Wistar rat epidermal biomacromolecules in vivo.
    Schoonderwoerd SA, Beijersbergen van Henegouwen GM, Persons KC.
    Arch Toxicol; 1991 Aug 15; 65(6):490-4. PubMed ID: 1929870
    [Abstract] [Full Text] [Related]

  • 20. Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity.
    Deeni YY, Ibbotson SH, Woods JA, Wolf CR, Smith G.
    PLoS One; 2013 Aug 15; 8(9):e75494. PubMed ID: 24086543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.